mravn holding ApS — Credit Rating and Financial Key Figures
CVR number: 40009051
Hasseltoften 39, 8361 Hasselager
mr@ravenbiosciences.com
tel: 20618627
Income statement (kDKK)
2020 | 2021 | 2023 | 2024 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | ||||
| Other operating expenses | -5.27 | -24.34 | ||
| EBIT | -5.27 | -24.34 | ||
| Other financial expenses | -0.03 | -1.19 | -1.11 | -1.09 |
| Income from other inv. held as non-curr. assets | 30.00 | |||
| Pre-tax profit | -0.03 | -1.19 | 23.62 | -25.43 |
| Net earnings | -0.03 | -1.19 | 23.62 | -25.43 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 20.00 | ||||
| Current deferred tax assets | 0.44 | 1.53 | 1.53 | 1.53 | |
| Short term receivables total | 20.44 | 1.53 | 1.53 | 1.53 | |
| Cash and bank deposits | 0.97 | 40.00 | 40.00 | 40.00 | 14.38 |
| Cash and cash equivalents | 0.97 | 40.00 | 40.00 | 40.00 | 14.38 |
| Balance sheet total (assets) | 21.41 | 41.52 | 41.52 | 41.52 | 14.38 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 0.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 20.00 | ||||
| Retained earnings | 1.44 | 2.71 | 1.53 | -22.09 | -0.20 |
| Profit of the financial year | -0.03 | -1.19 | 23.62 | -25.43 | |
| Shareholders equity total | 21.41 | 41.52 | 41.52 | 41.52 | 14.38 |
| Non-current liabilities total | |||||
| Current liabilities total | |||||
| Balance sheet total (liabilities) | 21.41 | 41.52 | 41.52 | 41.52 | 14.38 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.